buffer

(Rescheduled) Coronavirus Conversations: Behind COVID-19 - The Disease, The Effects, and The Treatments

05jun12:30 pm1:30 pm(Rescheduled) Coronavirus Conversations: Behind COVID-19 - The Disease, The Effects, and The Treatments

Location

Virtual Meeting

Time

(Friday) 12:30 pm - 1:30 pm(GMT+00:00) View in my time

Event Details

 

Rescheduled: Friday. June 5 2020, 12:30  PM (EDT) , Zoom

If you read the news about COVID-19 enough you may start to get confused about what exactly the disease is. What are the symptoms? What is the difference between mild and severe cases? What happens to the body when COVID-19 develops? What are the the treatments and are they effective? It can be difficult to know what information is accurate as more disinformation from bad actors takes hold of social media.

Join Duke Science & Society Director Nita Farahany as she talks with Dr. Cameron Wolfe – an infections disease specialist and leader of the Duke Remdesivir trial – as we demystify COVID-19 and learn about the disease causing global panic.

Panelists :

Dr. Cameron Wolfe, MBBS, Associate Professor of Medicine; Clinical Expert In Respiratory and Infectious Disease, Duke University

Dr. Nita Farahany, J.D., PhD, Director, Duke Initiative For Science & Society; Professor of Law and Philosophy, Duke University


Have an idea for a future Coronavirus Conversation?

 

Coronavirus Conversations: A new, virtual event series from Duke Science & Society

 

As we practice social distancing, engage in online learning, and work remotely we are burdened with questions about how this pandemic is affecting our lives, the lives of those we love, and the society we are a part of. Over the course of this event series faculty and staff from Duke Science and Society will join academics, lawmakers, students, researchers, doctors, and others to shed some light on the events happening around us and what life will start to look like moving forward.

We will have moderated, casual lunch-time discussions with brief Q&A held via Zoom chat.

Comments are closed.